Boldenone undecylenate is a veterinary injectable steroid. It is a derivative of testosterone, which exhibits strong anabolic and moderately androgenic properties. The undecylenate ether significantly prolongs the activity of the drug (the undecylenate ether is only one carbon atom longer than the decanoate), therefore, in clinical conditions, injections must be repeated every three to four weeks. In veterinary practice, Equipoise is used mainly on horses, having a pronounced effect on the consumed body weight, appetite and general temperament of the animal. Like all steroids, this compound shows a pronounced ability to increase the production of erythrocytes. In recent years, this compound has become popular among athletes. Many consider ego an ideal replacement for deca-durabolin. Equipoise is not a fast-acting mass gainer, but provides a slow but steady increase in strength and quality muscle mass. The most positive effect from the use of the drug is manifested in long cycles, usually lasting at least 10 weeks. The gained muscle mass should not be smooth and voluminous, as when using androgens, but should be very clear and strong.
COMPOSITION
250 mg/ml Boldenone undecylenate (10 ml VIAL)
SIDE EFFECTS
Side effects of Equipoise are usually mild. Boldenone's structure does allow it to convert to estrogen, but it does not have an extremely high affinity for it. If we look at aromatization studies, they show that the rate of conversion to estrogen should be approximately two times lower than that of testosterone. Therefore, water retention when using this drug will be slightly higher than when using Deca-Durabolin (with approximately 20% conversion), but much less than when using such a strong compound as testosterone. Although the possibility of encountering an estrogen-related side effect does exist when using Equipoise, at moderate dosages there are usually no problems. Gynecomastia can become a problem, but usually only in very sensitive people or in those who use higher dosages. If estrogenic effects become a problem, adding Nolvadex should certainly make the cycle more tolerable. Anti-aromatase drugs, such as Arimidex, Femara or Amonazin, would be a stronger option, but there is probably no need for such a mild drug.
APPLICATION
To maintain a stable level of the drug in the blood, Equipoise should be administered at least once a week. Most often, ego is used in a dosage of 400-600 mg per week for men, 50-150 mg per week for women.